Inovio Pharmaceuticals Inc (INO)

[Nascarrat]

Analyst upgrade to $18!

The 5-star analyst said, “Clearly, much investor focus is on INO-4800 and the opportunity in COVID-19. We would also point out that INO-4700, the DNA vaccine for another coronavirus (MERS, Middle Easter Respiratory Syndrome) will be presented at the ASGCT (American Society for Gene & Cell Therapy) this week, 5/12-5/15. Recall this program already reported positive data and in the COVID-19 vaccine race puts Inovio at a distinct advantage, in our view, that both Moderna and BioNTech do not have.”